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Determining the diversity of PfEMP1 sequences expressed by Plasmodium falciparum-infected erythrocytes
isolated from placentas is important for attempts to develop a pregnancy-specific malaria vaccine. The DBL
and var2csa DBL3x domains of PfEMP1 molecules are believed to mediate placental sequestration of infected
erythrocytes, so the sequences encoding these domains were amplified from the cDNAs of placental parasites
by using degenerate oligonucleotides. The levels of specific var cDNAs were then determined by quantitative
reverse transcription-PCR. Homologues of var2csa DBL3x were the predominant sequences amplified from the
cDNAs of most placental but not most children’s parasites. There was 56% identity between all placental
var2csa sequences. Many different DBL domains were amplified from the cDNAs of placental and children’s
isolates. var2csa transcripts were the most abundant var transcripts of those tested in 11 of 12 placental isolates
and 1 of 6 children’s isolates. Gravidity did not affect the levels of var2csa transcripts. We concluded that
placental malaria is frequently associated with transcription of var2csa but that other var genes are also
expressed, and parasites expressing high levels of var2csa are not restricted to pregnant women. The diversity
of var2csa sequences may be important for understanding immunity and for the development of vaccines for
malaria during pregnancy.
Malaria is more common in pregnant than nonpregnant
women and predisposes those infected to maternal and infant
death (37). The placenta provides a unique site for infected
erythrocytes (IE) to be sequestered through adhesion to re-
ceptors, including chondroitin sulfate A (CSA) and hyaluronic
acid (3, 14). IE from nonpregnant individuals rarely adhere to
CSA and hyaluronic acid (3). The restricted adhesion pheno-
type of parasites isolated from placentas is associated with the
expression of a restricted repertoire of parasite variant surface
antigens (VSAs). Consequently, with increasing parity, women
acquire antibodies that bind to parasites isolated from their
own and other placentas (1, 16). These antibodies are associ-
ated with protection (11, 16, 36), and some are capable of
blocking IE adhesion to CSA (2, 16, 39). It has therefore been
postulated that parasite sequestration in the placenta is caused
by a conserved, placenta-specific subset of VSAs.
Adhesion of IE is mediated predominantly by the diverse Plas-
modium falciparum erythrocyte membrane protein 1 (PfEMP1)
molecules encoded by the var multigene family. Each parasite
possesses approximately 60 var genes (20), and allogeneic par-
asites possess different repertoires of var genes. Previous stud-
ies linked adhesion to CSA to several var genes, including
var-CS2 (29) and FCR3.varCSA (6). In both cases, adhesion
was attributed to the DBL domain of PfEMP1. However,
subsequent studies have not corroborated these findings and
suggest that transcription of at least FCR3.varCSA is not asso-
ciated with adhesion to CSA (9, 10, 25, 35, 40, 41). A more
promising candidate CSA binding parasite ligand is the
VAR2CSA PfEMP1 identified by Salanti et al. (36). The most
abundant var transcript in multiple allogeneic CSA-adherent
parasites is var2csa (9, 12, 35), these parasites are antigenically
cross-reactive (12), and evidence of parity-dependent antibody
binding to defined, CSA-adherent laboratory isolates is cur-
rently restricted to parasites that express var2csa (2, 35). How-
ever, the identity of the conserved, CSA-binding parasite an-
tigen remains unresolved because parity-dependent antibodies
bind multiple recombinant proteins derived from both do-
mains of VAR2CSA (33) and the DBL domain of at least one
other PfEMP1 (5, 7). Furthermore, DBL domains present in
multiple PfEMP1 molecules and multiple domains of
VAR2CSA all bind to CSA (6, 18, 30).
Previous nonquantitative studies of the var genes expressed
by placental isolates have either used degenerate primers de-
signed to amplify multiple DBL domains or specific primers
to amplify DBL domains from some of the three var genes
identified as candidate CSA adhesion ligands (15, 22, 23, 32).
The amplification of multiple sequences and lack of quantita-
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tive data prevented the detection of a clear association be-
tween a specific var gene and placental sequestration. These
studies also did not detect var2csa because it lacks the DBL
and DBL domains for which the degenerate primers were
designed. Quantitative analyses of var transcription in placen-
tal isolates have been restricted to comparisons of var2csa and
FCR3.varCSA (35, 40). These studies were suggestive of a
major role for var2csa in malaria during pregnancy and ex-
cluded a similar role for FCR3.varCSA but did not address the
potential roles of other var genes possessing DBL domains
that may also have been transcribed at high levels in placental
isolates. We used degenerate primers capable of amplifying
both DBL domains and var2csa DBL3x domains to amplify a
range of transcribed var genes from parasites isolated from
placentas and from the peripheral blood of children. We then
used quantitative reverse transcription (Q-RT-PCR) on
cDNAs from the parasite isolates to determine the levels of
multiple var gene transcripts, including DBL sequences, that
had been amplified from the cognate cDNAs.
MATERIALS AND METHODS
Parasites. Informed consent was obtained from all patients or (for children)
their parents or guardians for participation in the study. The study was approved
by the College of Medicine Research and Ethics Committee, University of
Malawi, and the Royal Melbourne Hospital Clinical Research Ethics Committee.
P. falciparum-infected blood was obtained from placental biopsies from 19
women, as previously described (3), and from peripheral veins of six children
admitted with severe malaria at the Queen Elizabeth Central Hospital in
Blantyre, Malawi (31). Placental and peripheral blood samples were washed, and
the pellets were solubilized at a 1-in-10 dilution in Trizol (Invitrogen, Carlsbad,
CA) and stored frozen in liquid nitrogen. The Rplc series of placental isolates
was collected from 1997 to 1999 (32), while the Mplc placental samples and the
Mch children’s samples were collected from 1999 to 2001 (31).
DNA and total RNA preparation. Genomic DNA was isolated from 100 l of
packed erythrocytes by using a QIAmp DNA mini blood kit (QIAGEN, Hilden,
Germany) according to the manufacturer’s instructions. For RT-PCR, RNAs
were extracted from infected erythrocyte pellets solubilized in Trizol as described
previously (9). RNAs were treated for 2 h at 37°C with DNase I (4 U; Ambion,
Austin, TX) in the presence of total RNA carrier (Sigma, Sydney, Australia) and
with 40 U of RNasin RNase inhibitor (Promega, Madison, WI).
PCR and RT-PCR assays. Reverse transcription was performed as previously
described (9). Reverse transcriptase negative controls were used for each sample.
DBL and var2csa DBL3x sequences of approximately 600 bp were amplified
from cDNAs and genomic DNAs (gDNAs) from children’s and Mplc series
placental samples by PCRs using the degenerate oligonucleotides D3F (CCTC
CWAGRAGAMAAAAATTAT) and D3R1 (RCAAAAITSITCICKCCATTC)
(I stands for inosine). PCR was performed under the following conditions: 94°C
for 5 min, 40 cycles of 94°C for 30 s, 48°C for 30 s, and 65°C for 30 s, and a final
extension at 65°C for 6 min. PCR mixtures included 25 pmol of each primer, a
500 nM concentration of each deoxynucleoside triphosphate, and 2.5 mM MgCl2.
The Rplc series of samples was analyzed some time after the Mplc samples,
allowing an improved degenerate reverse primer (D3R1.2 [ACAAWANTSNT
CDBMCCATTC]) to be designed for amplification of the Rplc samples. D3R1.2
differed slightly in degeneracy from D3R1 but bound the same sequence.
To obtain additional DBL sequences from some samples, it was necessary to
use a seminested PCR that could only amplify DBL sequences. The seminested
PCR was performed in 50 l under the conditions described above, and the
mixture contained 0.5 l of the first-round PCR product as the template and the
primers D3F and D3R2 (CCATCKIARAAATTGIGGTYT). The use of a semi-
nested PCR increased the bias of amplification of particular sequences, but this
was controlled for by subsequent quantitative analyses.
cDNAs from the children’s isolates Mch1478 and Mch 1488 and from the
placental isolates from which var2csa cDNA could not be amplified using the
degenerate primers were subjected to PCR using a var2csa DBL3x-specific for-
ward primer (ACGATAAAGGTACAGCAATTATAT) and the same reverse
primer as that used for Q-RT-PCR (TGGTACCCAAAATCATATTCTTATA
ATCA).
All PCR products were cloned and sequenced using standard methods.
Q-RT-PCR. Absolute quantitation of var gene cDNAs by Q-RT-PCR was
performed as previously described, using standard curves of purified plasmids
containing var gene sequences (9). Briefly, each PCR used 5 l SYBR green
PCR master mix (PE Biosystems) in a 10-l reaction mix that was amplified using
the ABI Prism 7900HT sequence detection system. PCR mixtures were incu-
bated at 95°C for 10 min and then subjected to 40 cycles of 95°C for 15 s and 60°C
for 1 min. A final incubation of 95°C for 2 min was followed by a dissociation step
at 60°C for 2 min, with a 2% ramp rate to 95°C for 2 min. The specificity of each
primer pair was determined by dissociation curve analysis per the manufacturer’s
instructions. The primers used to amplify var2csa DBL3x (forward, TGTCATG
CTGTTCAAAGAAGTTTTATT; and reverse, TGGTACCCAAAATCATATT
CTTATAATCA) were designed using an alignment of the 3D7 and ItG var2csa
sequences and the 24 var2csa sequences amplified in this study. Nucleotide 16 of
the DBL3x reverse primer had a C-for-T mismatch with Mplc22.5, and nucleo-
tide 2 had a T-for-G mismatch with Rplc132c, Rplc132l, Rplc143d, and
Rplc143e. However, var2csa DBL3x sequences with 100% identity to the var2csa
DBL3x forward and reverse primers were also amplified from the same isolates.
Nucleotide 11 of the DBL3x forward primer had a C-for-T mismatch with the
only var2csa sequence amplified from Mplc78. Consequently, for quantitation of
var2csa in Mplc78 cDNA, the DBL3x forward primer was replaced with TGTC
ATGCTGCTCAAAGAAGTTTTATT, and the cloned Mplc78 var2csa sequence
was used to construct the standard curve. The primers used to amplify var-CS2
(forward, AGGAGATCAAGCAACCAC; and reverse, TTATTATCATCAAT
GTGTGTATCTCCTTTT) were identical to the var-CS2 sequence and the two
sequences amplified in this study from Mplc78. The primers used to amplify
FCR3var.CSA had the following sequences: TTGGAGGAATTTGCCAAACG
(forward) and CCATTCGGTTAGCCATCGTAAA (reverse). The quantities in
each cDNA of the skeleton binding protein 1 gene (SBP) (PFE_0065w) (forward,
TTAGCCGACGAACCAACACA; and reverse, TTCGGTTGTCTCTGGTAC
TGCA) and a hypothetical protein gene (PF11_0505) (forward, TTTCAAGGG
TCCAAGTTATGATGA; and reverse, AGGGCTTTGCCAAAAACTTTC)
were determined by Q-RT-PCR, using standard curves of diluted 3D7 isolate
gDNA. SBP and PF11_0505 levels were used to normalize the quantitative var
cDNA data. Other primers used are shown in Table 1.
Sequence analysis. Sequence analysis was performed using BioEdit (21).
Clustal W multiple sequence alignments with 100 bootstrap replicates were used
to create protein distance matrices and phylogenetic trees by the neighbor-
joining method (13) available at http://evolution.genetics.washington.edu/phylip
.html and by using TreeView (28), available at http://taxonomy.zoology.gla.ac.uk
/rod/treeview.html.
Nucleotide sequence accession numbers. The GenBank accession numbers for
all of the sequences reported in this study are AY461586 to AY461594,
AY464699, AY464700, AY466363 to AY466367, AY466369 to AY466372
AY488868 to AY488880, AY534318, AY534319, DQ286586 to DQ286636, and
DQ306266 to DQ306307.
RESULTS
The ability of the degenerate oligonucleotides D3F and
D3R1 (Fig. 1a) to amplify both DBL and var2csa DBL3x
sequences was tested by cloning products amplified from 3D7
genomic DNA. Forty clones were sequenced, yielding 9 of the
14 published 3D7 DBL sequences (26) and the var2csa
DBL3x sequence. After 40 cycles of amplification, the most
frequently amplified sequence (PFD0005w) was detected at 1.5
times the expected frequency using a binomial distribution,
as previously described (38) (Fig. 1b). Using the analysis of
Taylor et al. (39), these degenerate primers showed a low bias
towards amplification of the most frequently detected se-
quence of 2% (since 1.0240 is 1.5), which is consistent with
those of other “universal” DBL domain degenerate primers (8,
24, 38). Nevertheless, the bias may prevent the amplification of
some DBL sequences. The var2csa DBL3x sequence was am-
plified at a moderate frequency (Fig. 1b).
The oligonucleotides D3F and D3R1/D3R1.2 were then
used to amplify DBL and var2csa DBL3x sequences from the
cDNAs of 10 placental isolates and 4 isolates from the periph-
eral blood of children and from the gDNAs of 4 placental
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isolates and 1 child’s isolate (Table 1, sample group A). No
products could be amplified from the cDNAs of a further nine
placental and two children’s isolates (Table 1, sample group
B). The PCR products were cloned and sequenced (Table 1,
sample group A). A range of sequences were amplified from
the cDNAs of most isolates, but there was an obvious pattern
in the amplification of var2csa DBL3x sequences from the
cDNAs of all 10 placental isolates but not from the four children’s
isolate cDNAs (Table 1, sample group A) or the four placental
gDNAs amplified with D3R1 (Table 1, sample group A).
We wished to extend this analysis beyond previous studies by
first determining the endogenously transcribed DBL var se-
quence(s) in each isolate and then quantitating the level of
such a sequence in the cDNA of its cognate isolate to compare
with the levels of several var sequences that have been impli-
cated in adhesion to CSA in laboratory studies, including
var2csa DBL3x. To do this, we needed to clone DBL se-
quences from the isolates. Therefore, we used the degenerate
reverse primer D3R2, which could amplify only DBL se-
quences (Fig. 1), in a second round of RT-PCR amplification.
The second-round RT-PCR was performed on the two chil-
dren’s isolates and nine placental isolates from which no de-
tectable first-round product had been amplified using D3R1
(Table 1, sample group B) and on the placental isolates Mplc21
and Mplc22, from which only var2csa sequences had been
amplified using D3R1. The second-round primer D3R2 ampli-
fied DBL sequences from the cDNAs of both children’s iso-
lates and six of the nine placental isolates (Table 1, sample
group B) but not from the cDNAs of Mplc21 and Mplc22.
Combining the results from all degenerate primer PCRs,
DBL sequences were amplified from the cDNAs of 14 of the
19 placental isolates and all six of the children’s isolates (Table
1). There was a wide diversity in the DBL sequences ampli-
fied from the cDNAs of all samples. Sequences were also
amplified by either D3R1 or D3R2 from the gDNAs of a
randomly selected group of 10 isolates (Table 1, sample group
C) to test whether the sequences amplified from cDNAs simply
reflected primer bias. However, the sequences amplified from
TABLE 1. Data for placental and children’s isolates examined in this studya
Group Sample Reverseprimerb
No. of sequences amplified from:
Sample
used for
Q-RT-PCR
Endogenous
DBL control
for Q-RT-PCR
Primer sequence for endogenous DBL control
cDNA gDNA
var2csa
DBL3xc DBL
d var2csa
DBL3x DBL Forward Reverse
A Rplc132 D3R1.2 6 2 ND ND No ND
A Rplc134 D3R1.2 2 6 ND ND No ND
A Rplc136 D3R1.2 1 4 ND ND No ND
A Rplc143 D3R1.2 2 5 ND ND No ND
A Rplc154 D3R1.2 2 5 ND ND No ND
A Rplc294 D3R1.2 1 7 ND ND No ND
A, D Mch1485 D3R1 0 2 ND ND Yes Mch1485-1 TTATGAACAACACAAAT
AAAAACACCTTT
CATCACTGAATTTCAC
AGTGCCA
A, D Mch1481 D3R1 0 5 ND ND Yes Mch1481-4 AAAAAGCTGGAGGAAA
CGACAG
CCGTGTTGTAGTTGTA
AGTGGATTTG
A, D Mch1482 D3R1 0 4 ND ND Yes Mch1482-2 ATAATAACAGACGATAA
TTTGAAAGATGCT
TGCTGCTGCAGTTCTA
ATAAAAGC
A, C, D Mch1476 D3R1 0 3 0 2 Yes Mch1476-1 ATGAGAAAGAAATAGA
GAAAATGCGAA
AGTTGTAGGTCATGTT
CAGTTGTGTTC
A, C, D Mplc226 D3R1 2 3 0 6 Yes Mplc226-5 GTATCACGAGAAGATTG
GTGGAAA
CCCTTCCCATATTTGA
GGACAA
A, C, D Mplc154 D3R1 2 1 0 3 Yes Mplc154-1 GTCTTTCCGCAAACT
GCGA
CATTCACTGGTATTCC
CAGTGGT
A, C, D Mplc22 D3R1 5 0 0 4 Yes No control
A, C, D Mplc21 D3R1 2 0 0 2 Yes No control
B, C, D Mplc78 D3R2 0 (1) 2 0 6 Yes var-CS2
B, C, D Mplc178 D3R2 0 (1) 1 0 3 Yes Mplc178-1 TGGGATGAATATGCTCC
AGCT
TGATAGCCCACATAAC
ATTCCTTG
B, C, D Mplc132 D3R2 0 (0) 1 0 3 Yes Mplc132-1 AAGGGTCCCAAGAAAG
AACTAGATAA
TCCCCACCAAGCTACA
CGTT
B, C, D Mch1488 D3R2 0 (1) 3 0 7 Yes Mch1488-3 ATAATAACAGACGATAA
TTTGAAAGATGCT
TGCTGCTGCAGTTCTA
ATAAAAGC
B, C, D Mch1478 D3R2 0 (1) 3 0 3 Yes Mch1478-2 AATAATGGCGGCAAAT
CAGG
TTTCCACCAGTCTTCG
CGTT
B, D Mplc176 D3R2 0 (1) 2 ND ND Yes Mplc176-1 ATTTATTCCATAACAAA
AAAGTTTCTGCT
ACGCATTTATTAAATG
TGCTGCA
B, D Mplc345 D3R2 0 (1) 1 ND ND Yes Mplc345-1 GATGCAAAGTCCTCGAG
AGTAGATG
CAAAGACTACCAATAT
TCCACCGTT
B, D Mplc366 D3R2 0 (1) 2 ND ND Yes Mplc366-2 GCCACTGAATTTGACG
GTGG
TGCACTTACTAACAAG
GACACCTACAC
B, D Mplc129 NP (1) Yes No control
B, D Mplc159 NP (1) Yes No control
B, D Mplc328 NP (1) Yes No control
a NP, no PCR product; ND not done. Samples with the prefixes Mplc and Rplc are placental isolates, and samples with the prefix Mch are children’s isolates.
b The D3R1 degenerate primers were capable of amplifying both the DBL and var2csa DBL3x domains, while the nested D3R2 primers were only capable of
amplifying DBL domains.
c Number of different sequences with at least 77% identity to 3D7 var2csa DBL3x that were amplified from an isolate with the degenerate primers. Numbers in
parentheses indicate the numbers of var2csa sequences amplified by the specific var2csa primers.
d Number of different DBL sequences that were amplified from the isolate.
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gDNAs were different from those amplified from the cDNAs
of the same isolates, suggesting that the sequences amplified
from the cDNAs were detected because of their abundance.
An obvious association between placental isolate cDNA and
var2csa was revealed by a phylogenetic analysis that included
all of the amplified sequences and all of the PfEMP1 domains
previously implicated in pregnancy-associated malaria (6, 17,
23, 29, 32, 35) (Fig. 2). There was 76% identity between 3D7
var2csa and any of the 24 sequences homologous to var2csa
DBL3x identified in this study. However, only 56% of all 194
predicted amino acids were identical between all of the 22
full-length var2csa DBL3x sequences (excluding two sequences
that had large deletions) (see Fig. S1 in the supplemental
material). Four other DBL domains associated with ma-
laria in pregnancy formed small, well-supported clusters:
FCR3var.CSA DBL5 had at least 70% identity to four se-
quences from different placental cDNAs; FCR3var.CSA
DBL3 had 96% identity with two sequences from different
placental isolate cDNAs and one sequence from a child’s iso-
late cDNA; 3D7chr5var DBL3 (32), homologous to 720 (23)
and varCOMMON (42), had 79% identity with three sequences
from different placental cDNAs; and var-CS2 had 97% iden-
tity with the only two sequences amplified from a single pla-
cental cDNA.
We performed absolute quantitation by Q-RT-PCR to de-
termine quantitative relationships between selected pregnancy-
associated var sequences within those isolates for which suffi-
cient cDNA was available (Table 1, sample group D). This
group comprised all 6 children’s isolates and 13 of the placen-
tal isolates, including all 9 of the placental samples from which
no var2csa sequences were amplified with the degenerate
primers (Table 1, sample group B). For each cDNA, we quan-
titated the levels of var2csa DBL3x, var-CS2 DBL2, and
FCR3.varCSA DBL3. For all six children’s isolates and eight
of the placental isolates, we also quantitated the level of an
endogenous control DBL sequence that had been amplified
from the cDNA of the isolate being examined (Table 1 and Fig.
2). This controlled for the possibility that differences between
isolates in the levels of transcripts of any of the pregnancy-
associated var sequences merely reflected differences between
isolates in the levels of general var gene transcription. The
selected pregnancy-associated var sequences could not be used
to control for this possibility because the presence of these
sequences had not actually been established for all isolates. For
five placental samples, no endogenous control was used be-
cause no sequences could be amplified using the DBL degen-
erate primers. For sample Mplc78, the var-CS2 DBL se-
quence that was cloned from its cDNA was used as the
endogenous control.
Q-RT-PCR revealed that var2csa was the most abundant of
the transcripts examined for 12 of the 13 placental isolates
(sample group D) but that var-CS2 was a more abundant tran-
script than var2csa in the remaining placental isolate, Mplc78
(Fig. 3). FCR3var.CSA was present at a similar level to that of
var2csa in the cDNA from the placental isolate Mplc328. The
endogenous control DBL sequence was the most abundant of
the transcripts tested in four of the six children’s isolate
cDNAs, and var2csa was the most abundant of the transcripts
tested in the other two children’s isolate cDNAs (Mch1478 and
Mch1488) (Fig. 3). To confirm the presence of var2csa se-
quences in samples analyzed by Q-RT-PCR, we cloned and
sequenced var2csa PCR products that were amplified with
specific primers from the cDNAs of Mch1478, Mch1488, and
eight of the nine placental isolates from which var2csa could
not be amplified using the degenerate primers (Table 1, sample
group B). All but one of the cloned var2csa sequences were
identical to the var2csa sequence of the 3D7 isolate within the
region that was used as a template for Q-RT-PCR. The var2csa
sequence cloned from Mplc78 had a single mismatch of C
versus T at nucleotide 11 of the var2csa DBL3x Q-RT-PCR
FIG. 1. (a) Alignment of degenerate oligonucleotides D3F, D3R1,
and D3R2 with four DBL sequences that all bind CSA as recombi-
nant proteins (18) and with the DBL3x domain of the ItG var2csa
homologue (It4var4). Asterisks under the sequences indicate that the
nucleotides at those positions of the oligonucleotides had homology
with both DBL and DBL3X sequences. W, A or T; R, A or G; M, A
or C; Y, C or T; S, G or C; I, inosine. (b) Observed and expected
frequencies of detection of var2csa and different DBL sequences in
cloned PCR products amplified from 3D7 genomic DNA using the
oligonucleotides D3F and D3R1. Excel BINOMDIST was used to
calculate the expected binomial distribution for 40 sequenced clones
with 15 DBL or DBL3x possible identities if each identity was equally
likely (38).
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forward primer. Consequently, var2csa cDNA was quantitated
in the placental isolate Mplc78 by using both a modified
var2csa DBL3x forward primer that had a cytidine residue at
nucleotide 11 and a standard curve constructed from the
cloned Mplc78 var2csa sequence.
The absolute quantitation data were normalized to compare
the cDNA levels of specific var sequences between isolates and
to indicate the abundances of specific var sequences within an
isolate. The quantitative data should ideally be normalized to
the total level of var mRNA to control for fluctuations between
isolates in the levels of var gene transcripts caused by either
differences in the temporal stages of the parasites sampled or
FIG. 2. Phylogenetic tree of sequences amplified from cDNAs and gDNAs of parasites isolated from placentas and from peripheral blood of
children. The candidate CSA-binding PfEMP1s encoded by var2csa (35), FCR3.varCSA (6), var-CS2 (29), MAL6P14 (17), 3D7chr5var (32), 482,
498, 485, 720, and 732 (7, 23) are included, and those shown in bold are in the clusters described in the text. Bootstrap values of 50 are indicated
at tree branches leading to clusters of sequences. The sequences used as endogenous DBL controls for Q-RT-PCR are indicated with stars. The
sequences were named for the samples from which they were amplified, followed by a space and then a different number for each different
sequence from a single Mplc or Mch sample or a different letter for each different sequence from an Rplc sample. The suffix “-g” following an Mplc
or Mch sequence indicates that it was amplified from gDNA.
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differences in the peak levels of var mRNA transcribed by
allogeneic isolates. This was an issue in the current study be-
cause the peripheral blood samples from children contained
predominantly ring-stage parasites at the peak of var transcrip-
tion while the placental isolates were composed mainly of
mature trophozoites, in which var transcription is reduced.
However, the concentration of total, functional var cDNA can-
not be determined by Q-RT-PCR because the only sequences
that are sufficiently conserved between all var genes to be used
for this purpose are the second-exon sequences, which are also
present at high levels in mature parasites as sterile, truncated
transcripts. Consequently, to normalize the var Q-RT-PCR
data, we used two genes, namely, the skeleton binding protein
1 gene (SBP) (PFE_0065w) and a hypothetical protein gene
(PF11_0505), because their temporal transcriptional profile
closely approximated that of the var multigene family in allo-
geneic parasite strains 3D7, HB3, and Dd2 (4, 27). Therefore,
the normalized data presented in Fig. 4b represent the levels of
cDNAs for specific var genes in equivalent amounts of total var
cDNA from each isolate, as approximated by two control
genes.
We used a time course of CS2 parasites, in which var2csa is
the dominant var transcript (9), to validate our choice of genes
for normalization (Fig. 4a). The levels of the normalizing genes
were compared to the levels of var2csa in the 8-h postinvasion
ring-stage CS2 parasites and the 36-h postinvasion mature
trophozoite-stage CS2 parasites, using the following ratio: ring-
stage var2csa cDNA/ring-stage control gene cDNA:mature tro-
phozoite-stage var2csa cDNA/mature trophozoite-stage con-
trol gene cDNA. This gave ratios of 2.5:1 for SBP and 1.3:1 for
PF11_0505. Thus, we assumed that the mature trophozoites in
the placental isolates would contain 2.5-fold more var tran-
scripts than were calculated by using SBP for normalization
and 1.3-fold more var transcripts than were calculated by using
PF11_0505 for normalization, and we adjusted the normalized
data accordingly. The levels of 18S rRNA were also quanti-
tated in the CS2 parasites to show that the similar transcrip-
tional profiles of var2csa, PF11_0505, and SBP did not merely
reflect the use of decreased parasite cDNA in the mature
trophozoite Q-RT-PCR (Fig. 4a). The levels of SBP in the 12
placental and 6 children’s isolates analyzed (Table 1, sample
group D) correlated with the levels of PF11_0505 (R2 
0.8812), corroborating the evidence of their similar temporal
transcriptional profiles in 3D7, HB3, Dd2, and CS2 parasites.
The placental sample Mplc345 was omitted from the normal-
ized data analysis because it contained insufficient levels of
cDNA from either normalizing gene.
In data normalized with either control gene (Fig. 4b), there
was significantly more var2csa cDNA in the placental isolates
than in the children’s isolates (Table 2) (Mann-Whitney test;
P  0.0043 [SBP] or 0.017 [PF11_0505]) but no significant
difference in the levels of var2csa associated with gravidity.
There was significantly more var2csa cDNA than endoge-
nous control DBL cDNA in the placental isolates (Table 2)
(Mann-Whitney test; P 0.0009 [SBP] or 0.0023 [PF11_0505])
but not in the children’s isolates (Table 2) (Mann-Whitney
test). The median levels of endogenous control DBL se-
quences were higher for cDNAs from the children’s isolates
than for those from the placental isolates, but the difference
was not significant (Table 2) (Mann-Whitney test). The most
abundant var transcript in CS2 parasites is var2csa (9), so the level
of var2csa in CS2 cDNA indicates the abundance of specific var
sequences in the cDNAs of the other samples (Fig. 4b). The
abundance of var2csa cDNA in the child’s isolate Mch1478 was
apparent in the normalized data, but only a low level of var2csa
was present in cDNA from the other child’s isolate (Mch1488) in
which var2csa was the most abundant of the analyzed var tran-
scripts (Fig. 4b).
The abundance of var-CS2 in the placental isolate Mplc78
was apparent in the normalized data (Fig. 4b). The placental
FIG. 3. Percentage that each var gene constituted of the total var cDNA for the three or four var genes examined in each isolate by Q-RT-PCR
absolute quantitation. Three var genes were quantitated for Mplc78 and for the five placental isolates with the prefix “(ne)-,” from which no
endogenous control DBL sequence could be amplified; four var genes were quantitated for the other 13 isolates. Endogenous refers to the
endogenous DBL sequence that was amplified from the sample being analyzed.
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isolate Mplc328 contained similar but low normalized levels of
var2csa DBL3x and FCR3var.CSA DBL3 cDNAs (Fig. 4b).
The median values for FCR3var.CSA DBL3 sequences were
higher for placental cDNAs than for children’s cDNAs, but the
difference was not significant (Table 2) (Mann-Whitney test).
DISCUSSION
Our degenerate primer RT-PCR analysis revealed a similar
diversity of transcribed DBL domains in placental isolates to
that reported in previous studies (15, 22, 23, 32) but also
revealed that var2csa was transcribed in all 10 placental isolates
from which D3F and D3R1/D3R1.2 could amplify a product
(Table 1, sample group A). This apparent dominance of
var2csa DBL3x domains over DBL domains in the mRNAs of
placental isolates was corroborated by the evidence of a low
bias of primers D3F and D3R1 towards amplification of
var2csa from 3D7 gDNA and by their ability to amplify var2csa
from the cDNAs but not the gDNAs of the four placental
isolates tested (Table 1, sample group A).
FIG. 4. (a) cDNA levels in CS2 parasites of var2csa, 18S rRNA, and the two genes, PF11_0505 and the SBP gene (PFE-0065w), that were used
to normalize the Q-RT-PCR data. (b) Absolute quantities of var cDNA levels in placental (Mplc) and children’s (Mch) isolates were determined
by Q-RT-PCR, using standard curves, and the data were then normalized using the levels of SBP and PF11_0505 cDNAs. Consequently, the data
shown represent the cDNA levels of specific var genes in equivalent amounts of total var cDNA from each isolate, as estimated using two control
genes that approximate the transcriptional profile of var genes. The gravidity of the patient from whom each placental isolate was obtained is
indicated in parentheses after the title of the isolate. Endogenous refers to the endogenous DBL sequence that was amplified from the sample
being analyzed. The prefix “(ne)-” indicates that no endogenous DBL sequence control was available for that sample.
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Further quantitative analysis revealed that var2csa was the
most abundant of the analyzed var transcripts in 12 of the 13
placental isolates examined (Table 1, sample group D), sup-
porting the association between var2csa transcripts and para-
sites sequestered in the placenta (35, 40). The significantly
higher levels of var2csa than of endogenous DBL sequences
in the placental cDNAs suggested that the high levels of
var2csa cDNA in these placental isolates did not simply reflect
high levels of total var gene cDNA. This conclusion was sup-
ported by the lower levels of endogenous DBL sequences in
the placental than in the children’s isolate cDNAs. Although
this difference was not significant, it suggested that, if anything,
there was less transcription of var genes (other than var2csa)
in the placental than in the children’s isolates. It is quite pos-
sible that the two children’s isolates in which var2csa was the
most abundant of the analyzed var transcripts expressed other
var genes lacking DBL domains at higher levels than var2csa.
We did not look specifically for these, but the level of var2csa
remained high in the normalized data for one of these children
(Mch1478), indicating that var2csa can be an abundant tran-
script in nonpregnant individuals. Only low levels of var2csa
transcripts have been described previously for nonpregnant
individuals (35, 40).
The var-CS2 DBL2 domain was the only var transcript
tested that was present at higher levels than var2csa in a pla-
cental isolate, suggesting that it may play a role in placental
sequestration. Interestingly, parasites with disrupted var2csa
that bind bovine trachea CSA in vitro also transcribe var-CS2
at high levels (10), strengthening previous associations be-
tween transcription of this gene and adhesion to CSA (29, 30).
The similar but low levels of FCR3var.CSA DBL3 and var2csa
sequences in the cDNA of the placental isolate Mplc328
suggest the existence of an abundant, unidentified var gene
transcript in this isolate rather than indicating a role for
FCR3var.CSA DBL3 in placental sequestration of this iso-
late. Although there were higher normalized levels of the
FCR3var.CSA DBL3 sequence in cDNAs from mature pla-
cental parasites than in those from ring-stage parasites infect-
ing children, the difference was not significant, and this prob-
ably simply reflects the atypically late peak of FCR3var.CSA
transcription (25).
A role in placental sequestration cannot be excluded for
PfEMP1s carrying domains homologous to the 3D7chr5var
DBL3/720 and FCR3var.CSA DBL5 domains that were
transcribed by the Rplc series of placental cDNAs (Fig. 2).
Like all other domains implicated in pregnancy-associated ma-
laria, the FCR3var.CSA DBL5 domain, which is homologous
to 3D7chr5var DBL5, was previously amplified from placen-
tal isolate cDNA (15, 32). However, this domain is part of an
unusually conserved subset of var genes (34) that are fre-
quently transcribed by parasites infecting nonpregnant individ-
uals (42), and unlike all other domains implicated in preg-
nancy-associated malaria, recombinant proteins derived from
FCR3var.CSA DBL5 do not bind CSA (6, 18, 19). These
sequences were amplified from the Rplc placental cDNAs that
had also previously been used to survey DBL domain tran-
scription (32). Unfortunately, there was insufficient material
available from the Rplc samples to quantitate these sequences
by Q-RT-PCR.
We concluded that var2csa was probably the principal var
gene transcribed by parasites sequestered in the placentas of
most of the participants in this study. However, the abundance
of var-CS2 in one placental isolate suggests that parasites tran-
scribing var genes other than var2csa can be sequestered in the
placenta. Larger studies must determine whether var2csa is
the dominant var transcript in placental isolates from around
the globe if var2csa is to be explored as a possible candidate for
vaccination against malaria during pregnancy. Also, note the
diversity within the small sample of var2csa DBL3x sequences
isolated from one locale and examined in this study. This
indicates that it may be difficult to develop a vaccine from a
single var2csa DBL3x sequence, and thus it is essential to
identify the most conserved regions of var2csa that elicit func-
tional immunity.
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